Sarepta Therapeutics
SRPT
SRPT
344 hedge funds and large institutions have $9.89B invested in Sarepta Therapeutics in 2018 Q3 according to their latest regulatory filings, with 72 funds opening new positions, 114 increasing their positions, 107 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
7% more repeat investments, than reductions
Existing positions increased: 114 | Existing positions reduced: 107
0.68% more ownership
Funds ownership: 91.5% → 92.18% (+0.68%)
31% less funds holding in top 10
Funds holding in top 10: 13 → 9 (-4)
Holders
344
Holding in Top 10
9
Calls
$444M
Puts
$334M
Top Buyers
| 1 | +$307M | |
| 2 | +$117M | |
| 3 | +$66.4M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$65.7M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$65.6M |
Top Sellers
| 1 | -$107M | |
| 2 | -$74.8M | |
| 3 | -$68M | |
| 4 |
Renaissance Technologies
New York
|
-$62.6M |
| 5 |
BC
Boxer Capital
San Diego,
California
|
-$49.6M |